Chennai-based medical technology firm Trivitron Healthcare has raised Rs 150 crore from India Value Fund (IVF) in return for a minority stake.
The private equity company has purchased the stake held by ePlanet Ventures Mauritius Ltd and Hav2 (Mauritius) Ltd, which had invested in the company in 2007.
A portion of IVF’s investment will also fund Trivitron’s expansion plans. Fidelity Capital Management Ltd and its affiliates, which had entered the company last year, continue to hold their stakes.
Mumbai-headquartered IVF has a history of healthcare-related investments: it had earlier invested in Biocon, TTK Healthcare, Care Hospitals, DM Healthcare and Manipal Hospitals.
Venkat Subramanyam, Founder and Director, Veda Corporate Advisors, which advised Trivitron and exiting investors in this deal, says the prospects for companies in the healthcare sector are bright, and more such deals can be expected in this segment.